This podcast episode explores the Adderall shortage in the United States, its causes, and the impact on individuals. The episode highlights the increasing demand driven by telehealth companies, the DEA's strict regulations, and the experiences of individuals who abuse Adderall. It also delves into the role of telehealth companies in contributing to the shortage and the challenges faced by individuals as a result.
